Idarubicin: Mechanism of Action, Side Effects, and Clinical Applications in Cancer Treatment
Idarubicin 57852-57-0is a potent chemotherapy drug belonging to the anthracycline class, primarily used in the treatment of various types of cancer, including acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL). Its mechanism of action, side effects, and clinical applications make it a crucial component of cancer treatment regimens.Mechanism of Action:Idarubicin exerts its anticancer effects by interfering with the DNA and RNA synthesis of cancer cells. It does so by intercalating between DNA base pairs, inhibiting the activity of topoisomerase II enzyme, and generating free radi [...]